These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 21357472)

  • 21. Bmal1 is required for beta cell compensatory expansion, survival and metabolic adaptation to diet-induced obesity in mice.
    Rakshit K; Hsu TW; Matveyenko AV
    Diabetologia; 2016 Apr; 59(4):734-43. PubMed ID: 26762333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjudin improves beta cell maturation, hepatic glucose uptake and glucose homeostasis.
    Ren L; Charbord J; Chu L; Kemas AM; Bertuzzi M; Mi J; Xing C; Lauschke VM; Andersson O
    Diabetologia; 2024 Jan; 67(1):137-155. PubMed ID: 37843554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of combining linagliptin treatment with BI-38335, a novel SGLT2 inhibitor, on pancreatic islet function and inflammation in db/db mice.
    Chen L; Klein T; Leung PS
    Curr Mol Med; 2012 Sep; 12(8):995-1004. PubMed ID: 22804249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance.
    Skovsø S; Panzhinskiy E; Kolic J; Cen HH; Dionne DA; Dai XQ; Sharma RB; Elghazi L; Ellis CE; Faulkner K; Marcil SAM; Overby P; Noursadeghi N; Hutchinson D; Hu X; Li H; Modi H; Wildi JS; Botezelli JD; Noh HL; Suk S; Gablaski B; Bautista A; Kim R; Cras-Méneur C; Flibotte S; Sinha S; Luciani DS; Nislow C; Rideout EJ; Cytrynbaum EN; Kim JK; Bernal-Mizrachi E; Alonso LC; MacDonald PE; Johnson JD
    Nat Commun; 2022 Feb; 13(1):735. PubMed ID: 35136059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prostaglandin E
    Neuman JC; Reuter A; Carbajal KA; Schaid MD; Kelly G; Connors K; Kaiser C; Krause J; Hurley LD; Olvera A; Davis DB; Wisinski JA; Gannon M; Kimple ME
    Am J Physiol Endocrinol Metab; 2024 May; 326(5):E567-E576. PubMed ID: 38477664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass.
    Peyot ML; Pepin E; Lamontagne J; Latour MG; Zarrouki B; Lussier R; Pineda M; Jetton TL; Madiraju SR; Joly E; Prentki M
    Diabetes; 2010 Sep; 59(9):2178-87. PubMed ID: 20547980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation.
    Burke SJ; Batdorf HM; Burk DH; Martin TM; Mendoza T; Stadler K; Alami W; Karlstad MD; Robson MJ; Blakely RD; Mynatt RL; Collier JJ
    Mol Metab; 2018 Aug; 14():95-107. PubMed ID: 29914854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.
    Vallon V; Rose M; Gerasimova M; Satriano J; Platt KA; Koepsell H; Cunard R; Sharma K; Thomson SC; Rieg T
    Am J Physiol Renal Physiol; 2013 Jan; 304(2):F156-67. PubMed ID: 23152292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Swertisin, a novel SGLT2 inhibitor, with improved glucose homeostasis for effective diabetes therapy.
    Bhardwaj G; Vakani M; Srivastava A; Patel D; Pappachan A; Murumkar P; Shah H; Shah R; Gupta S
    Arch Biochem Biophys; 2021 Oct; 710():108995. PubMed ID: 34289381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.
    Conarello SL; Jiang G; Mu J; Li Z; Woods J; Zycband E; Ronan J; Liu F; Roy RS; Zhu L; Charron MJ; Zhang BB
    Diabetologia; 2007 Jan; 50(1):142-50. PubMed ID: 17131145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic, but not myeloid-cell, expression of interleukin-1alpha is required for maintenance of insulin secretion and whole body glucose homeostasis.
    Collier JJ; Batdorf HM; Martin TM; Rohli KE; Burk DH; Lu D; Cooley CR; Karlstad MD; Jackson JW; Sparer TE; Zhang J; Mynatt RL; Burke SJ
    Mol Metab; 2021 Feb; 44():101140. PubMed ID: 33285301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of the kidneys in glucose homeostasis. Implication of sodium-glucose cotransporter 2 (SGLT2) in diabetes mellitus treatment].
    Girard J
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S35-S41. PubMed ID: 28577741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic Islet APJ Deletion Reduces Islet Density and Glucose Tolerance in Mice.
    Han S; Englander EW; Gomez GA; Rastellini C; Quertermous T; Kundu RK; Greeley GH
    Endocrinology; 2015 Jul; 156(7):2451-60. PubMed ID: 25965959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity.
    Yamamoto K; Uchida S; Kitano K; Fukuhara N; Okumura-Kitajima L; Gunji E; Kozakai A; Tomoike H; Kojima N; Asami J; Toyoda H; Arai M; Takahashi T; Takahashi K
    Br J Pharmacol; 2011 Sep; 164(1):181-91. PubMed ID: 21410690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
    Bonner C; Kerr-Conte J; Gmyr V; Queniat G; Moerman E; Thévenet J; Beaucamps C; Delalleau N; Popescu I; Malaisse WJ; Sener A; Deprez B; Abderrahmani A; Staels B; Pattou F
    Nat Med; 2015 May; 21(5):512-7. PubMed ID: 25894829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney.
    Luo J; Hu S; Fu M; Luo L; Li Y; Li W; Cai Y; Dong R; Yang Y; Tu L; Xu X
    J Biol Chem; 2021; 296():100667. PubMed ID: 33864813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SERCA2 Deficiency Impairs Pancreatic β-Cell Function in Response to Diet-Induced Obesity.
    Tong X; Kono T; Anderson-Baucum EK; Yamamoto W; Gilon P; Lebeche D; Day RN; Shull GE; Evans-Molina C
    Diabetes; 2016 Oct; 65(10):3039-52. PubMed ID: 27489309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of an SGLT2-loss of function mutation on renal architecture, histology, and glucose homeostasis.
    Hughes CB; Mussman GM; Ray P; Bunn RC; Cornea V; Thrailkill KM; Fowlkes JL; Popescu I
    Cell Tissue Res; 2021 May; 384(2):527-543. PubMed ID: 33409652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic deletion of miR-204 improves glycemic control despite obesity in db/db mice.
    Gaddam RR; Kim YR; Li Q; Jacobs JS; Gabani M; Mishra A; Promes JA; Imai Y; Irani K; Vikram A
    Biochem Biophys Res Commun; 2020 Nov; 532(2):167-172. PubMed ID: 32950230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.
    Yoshii A; Nagoshi T; Kashiwagi Y; Kimura H; Tanaka Y; Oi Y; Ito K; Yoshino T; Tanaka TD; Yoshimura M
    Cardiovasc Diabetol; 2019 Jul; 18(1):85. PubMed ID: 31262297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.